Juno Therapeutics files for IPO, a year after founding, seeking $150M for cancer breakthroughs Juno Therapeutics, a heavily funded biotech company with a novel approach to fighting cancer, filed plans for an initial public… Read More
Amazon CEO Jeff Bezos backs cancer research startup Juno Therapeutics Juno Therapeutics, a new Seattle startup that’s trying to eliminate cancer from the human body, raised a hefty $120 million… Read More
With $120M in its pocket, Juno Therapeutics aims to wipe out cancer by rewiring the immune system One big problem with existing cancer therapies available today like chemotherapy and radiation is the collateral damage. While some medicine… Read More
Cancer research startup Juno Therapeutics raises $120M in massive series A financing In one of the largest series A venture capital deals this year in the biotechnology sector, Seattle-based Juno Therapeutics has… Read More
